MMMarlene R. Moster

Marlene R. Moster

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marlene R. Moster has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Explantation of the Novel Ahmed Glaucoma Valve M4 Implant

    by Wanda D. Hu, Michael J. Pro, Scott J. Fudemberg, Marlene R. Moster

    To report a series of cases involving Ahmed Glaucoma Valve M4 (AGV) explantation and to discuss the surgical technique to remove the drainage device. Four cases were identified that presented with AGV M4 postoperative complications necessitating tube shunt removal. Three patients presented with conjunctival erosion and 1 patient with persistent diplopia. AGV M4 implants were removed successfully between 1.5 and 9 months after implantation. Successful explantation of the AGV M4 novel implant was achieved in all cases without intraoperative or postoperative complications. If necessary, AGV M4 explantation can be successfully performed in the early postoperative period.


  • Intracameral Triamcinolone Acetonide in Glaucoma Surgery: A Prospective Randomized Controlled Trial

    by Michael S. Koval, Marlene R. Moster, Kathryn B. Freidl, Michael Waisbourd, Shelly G. Jain, Parul Ichhpujani, Jonathan S. Myers, Michael J. Pro


  • Complications of Glaucoma Surgery

    by Marlene R. Moster, Augusto Azuara-Blanco

  • Open Access

    A Comfort Survey of Timolol Hemihydrate 0.5% Solution Once or Twice Daily vs Timolol Maleate in Sorbate

    by Parul Ichhpujani, William C Stewart, Jeffrey C Oehler, Neil T Choplin, Joseph I Markoff, Marlene R Moster, Lindsay A Nelson

    To evaluate by survey the comfort upon instillation of timolol hemihydrate compared to timolol maleate with potassium sorbate. A prospective, multicenter, observational, non-interventional study. One hundred and three patients of open-angle glaucoma or ocular hypertension who were ≥21 years old and were currently prescribed timolol hemihydrate (once or twice daily) or timolol maleate with potassium sorbate once daily as monotherapy or as a part of two-drug therapy. Study was performed at seven clinical sites in the United States. Patients were surveyed on comfort upon instillation of timolol hemihydrate compared to timolol maleate with potassium sorbate. A difference between timolol hemihydrate and timolol maleate with potassium sorbate for questions 1 (burning/stinging on instillation, p < 0.001) and 4 (tearing on instillation, p = 0.024) was noted. There were no differences between treatment groups for any other question (p > 0.05). This survey suggests that timolol hemihydrate is associated with less stinging/burning and tearing than timolol maleate with potassium sorbate. How to cite this article: Stewart WC, Oehler JC, Choplin NT, Markoff JI, Moster MR, Ichhpujani P, Nelson LA. A Comfort Survey of Timolol Hemihydrate 0.5% Solution Once or Twice Daily vs Timolol Maleate in Sorbate. J Current Glau Prac 2013;7(1):11-16.


  • Open Access

    The Blitz Anesthesia Technique in Non-English Speaking Patients Undergoing Glaucoma Surgery

    by Parul Ichhpujani, Arun Prasad, Scott J Fudemberg, Marlene R Moster

    To describe a less invasive method of providing anesthesia in non-English speaking patients undergoing glaucoma surgery. Prospective observational study conducted in a tertiary Care Eye Institute, Wills Eye Institute, Philadelphia, PA, USA. The blitz anesthesia technique was applied to 15 non-English speaking patients (Vietnamese, Mandarin, Russian and Korean) during glaucoma surgery. With input from family members, a diagram was created for each patient. The diagram consisted of a translation and phonetic guide to pronunciation of common words or phrases in the patient's native language that might be used by the surgical team during the operation. The blitz anesthesia technique worked well to provide patient comfort during the procedures. All patients reported adequate pain control and described their experience as comfortable. Additionally, patients reported feeling reassured that they were able to understand basic information from the surgical team during their case. This technique decreased patient anxiety prior to and during the surgical procedure. Blitz anesthesia provided adequate pain control with no complications. Blitz anesthesia with a phonetic language diagram, a less invasive technique of providing anesthesia in non-English speaking patients undergoing glaucoma surgery. Almodin J, Ichhpujani P, Prasad A, Fudemberg SJ, Moster MR. The Blitz Anesthesia Technique in Non-English Speaking Patients Undergoing Glaucoma Surgery. J Current Glau Prac 2012;6(2):91-93.

  • Direct Cyclopexy with a Posterior Infusion Cannula

    by Michael Rabinowitz, Parul Khator, Chirag P. Shah, Parul Ichhpujani, Marc J. Spirn, Marlene R. Moster

    Numerous surgical procedures have been proposed for cyclodialysis cleft repair. The authors describe a novel technique of cyclopexy with posterior infusion cannula in a patient with persistent hypotony and maculopathy secondary to a large cyclodialysis cleft after trauma.


  • Intermediate‐term results of the Ex‐PRESS miniature glaucoma implant under a scleral flap in previously operated eyes

    by Dara Lankaranian, M Reza Razeghinejad, Arun Prasad, Ghasem Fakhraie, Daniel J Freitas, Parul Ichhpujani, Marlene R Moster

    Background:  To report the safety and efficacy of Ex‐PRESSTM miniature glaucoma implant under a scleral flap in patients with previous ocular surgeries.Design:  Retrospective, non‐comparative case series from a tertiary care hospital.Participants:  Patients with previous cataract or failed glaucoma surgeries who had undergone implantation of the Ex‐PRESSTM miniature glaucoma implant (R‐50 and T‐50), under a scleral flap, with a minimum of 1‐year postoperative follow up.Methods:  For postoperative outcome, success was defined as complete if intraocular pressure (IOP) was 5–21 mmHg without medication or surgical intervention, and qualified if intraocular pressure was within the same range with glaucoma medication. To compare the outcome between patients who had previous trabeculectomy or cataract surgery the definition of success was intraocular pressure of 5–15 mmHg.Main Outcome Measures:  Intraocular pressure, number of antiglaucoma drugs, visual acuity and complications.Results:  One hundred eyes (100 patients; mean age: 77.4 years) with a mean follow‐up period of 27 ± 13.2 months (range: 12–66) were considered. Success was complete in 60 (60%) and qualified in 24 (24%) eyes. The mean preoperative IOP of 27.7 ± 9.2 mmHg (range: 14–52 mmHg) with 2.73 ± 1.1 drugs declined to 14.02 ± 5.1 mmHg with 0.72 ± 1.06 drugs at the last follow up (P < 0.0001). Causes of failure were uncontrolled intraocular pressure (11%), bleb needling (4%) and persistent hypotony (1%). The probability of success in the patients with previous cataract surgery and trabeculectomy at 3 years was 60.6% and 50.9%, respectively.Conclusions:  The Ex‐PRESSTM implant under scleral flap was a safe and effective glaucoma surgery in the eyes with prior ocular surgery.


  • Anesthesia

    by Marlene R. Moster, Augusto Azuara-Blanco

  • Use of Tisseel Fibrin Sealant to Manage Bleb Leaks and Hypotony

    by Audrey Do Seligsohn, Marlene R. Moster, William Md Steinmann, Joann Fontanarosa